Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 8/20 | 0.52 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | F10 | P00742 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23972094 | 0.79 | HIF1A (0.60) | HIF1ARAB9ASMN1; SMN2NPC1LMNA | |
| SCHEMBL23971812 | 0.79 | HIF1A (0.50) | HIF1ASLC6A2SLC6A4SLC6A3RAB9A | |
| SCHEMBL12557397 | 0.78 | HIF1A (0.55) | HIF1ARAB9ANPC1KMT2A | |
| SCHEMBL23972091 | 0.78 | HIF1A (0.67) | HIF1ARAB9ASMN1; SMN2NPC1LMNA | |
| SCHEMBL20698666 | 0.78 | HIF1A (0.48) | HIF1ARAB9ASMN1; SMN2NPC1L3MBTL1 | |
| SCHEMBL23972069 | 0.78 | HIF1A (0.61) | HIF1ARAB9ANPC1LMNAKMT2A | |
| SCHEMBL7127228 | 0.78 | HIF1A (0.59) | HIF1ARAB9ASMN1; SMN2NPC1LMNA | |
| SCHEMBL7127227 | 0.78 | HIF1A (0.59) | HIF1ARAB9ASMN1; SMN2NPC1LMNA | |
| SCHEMBL13054270 | 0.78 | HIF1A (0.61) | HIF1ALMNAKMT2AHPGD | |
| SCHEMBL8444517 | 0.77 | HIF1A (0.60) | HIF1ALMNAKMT2AHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10906880-B2 | Kind of isothiazole oxime ether-containing strobilurin derivatives and its preparation methods and application | NANKAI UNIVERSITY (CN) | 2021-02-02 | — | — | US | disclosed |
| US-20190031627-A1 | A KIND OF ISOTHIAZOLE OXIME ETHER-CONTAINING STROBILURIN DERIVATIVES AND ITS PREPARATION METHODS AND APPLICATION | NANKAI UNIVERSITY (CN) | 2019-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10906880-B2 | Kind of isothiazole oxime ether-containing strobilurin derivatives and its preparation methods and application | STS, STAU1, CDV3 | HIF1A 3135/4885SLC6A2 4618/4885SLC6A4 4010/4885 |
| US-20190031627-A1 | A KIND OF ISOTHIAZOLE OXIME ETHER-CONTAINING STROBILURIN DERIVATIVES AND ITS PREPARATION METHODS AND APPLICATION | STS, CDV3, SALL4 | HIF1A 3136/4885SLC6A2 4636/4885SLC6A4 3946/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.